Worth reading
53Recurring
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
435000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly exercise status of stock acquisition rights with an exercise price adjustment clause
発行・処分する株式数
Number of shares delivered during the month: 435,000 shares (435,000 new shares; no transfer of treasury shares)
Existing Shares and Increase
+1.18%Rate of increase
82,786,758 shares83,221,758Shares
Exercise ratio during the month: 1.18% of the total number issued. Exercise ratio subject to exercise restrictions: 0.60%
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise price during the month: ¥111–¥127. Details of the adjustment clause and the floor price: Not disclosed
Number of Stock Acquisition Rights
Total number issued: Not disclosed. Number of remaining unexercised rights as of the end of the preceding month: 275,750. Number of remaining unexercised rights as of month-end: 271,400
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Transactions.
Most recent equity financing
Timing 30 October 2025 / Type Issuance of the 22nd Series of Stock Acquisition Rights (with exercise price adjustment clause) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of stock acquisition rights with an exercise price adjustment clause |
| Number of shares to be issued or disposed of | Number of shares delivered during the month: 435,000 shares (435,000 new shares; no transfer of treasury shares) |
| Dilution Rate | Exercise ratio during the month: 1.18% of the total number issued. Exercise ratio subject to exercise restrictions: 0.60% |
| Total number of issued shares | 82,786,758 shares (as of the end of the month preceding the month under review) → 83,221,758 shares (the number of shares outstanding at the end of the preceding month plus the 435,000 shares delivered during the month under review) |
| Exercise price | Exercise price during the month: ¥111–¥127. Details of the adjustment clause and the floor price: Not disclosed |
| Number of Stock Acquisition Rights | Total number issued: Not disclosed. Number of remaining unexercised rights as of the end of the preceding month: 275,750. Number of remaining unexercised rights as of month-end: 271,400 |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Transactions. |
| Most recent equity financing | Timing 30 October 2025 / Type Issuance of the 22nd Series of Stock Acquisition Rights (with exercise price adjustment clause) / Amount Not disclosed |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of the 22nd Series of Stock Acquisition Rights (with Exercise Price Adjustment Clause) for May 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.